The president has signed the Consolidated Appropriations Act of 2021 (COVID Relief Act) mitigating, in part, the looming Part B Fee Schedule reduction that was slated for January 1, 2021.
CMS will be taking time in January to recalculate the impact of the changes in the law and publicize those changes to stakeholders.
Please reach out with questions – we’re here to support you!
Congress has passed the Consolidated Appropriations Act of 2021 (H.R. 133). Industry advocacy stressing the urgency of addressing the Part B Fee Schedule cuts that were slated to take effect January 1, 2021 were clearly heard! This legislation is currently pending presidential signature.
Partial relief was found in a 3-year moratorium placed on the add-on code for inherently complex evaluation and management visits which the fee schedule cuts were designed to offset. This should reportedly result in about a third of the E/M related savings through a recalculation of the conversion factor.
Additional items that were highlighted in NASL’s overview of items within the COVID relief package impacting therapy reimbursement include the following:
Blocking of the new add-on fee schedule complexity code (G2211) – formerly GPC1X - for three years, mitigates the E/M cuts by a projected third.
Injection of $3 billion of new money into the PFS in 2021 (for one year only), results in 3.75% payment increases across the board helping all Medicare providers during the ongoing COVID-19 pandemic.
Delay of the 2 percent Medicare sequester cuts that were supposed to resume January 1, 2021, for three months. The value of this is approximately $3 billion over 3 months.
Let's Get to the Point:
We are closely watching the president's reaction to this relief package and the impact to our clients and those they serve. We will continue to provide updates and approaches to ensure patient care remains the priority.